Summit Therapeutics Inc. Shares Outstanding (Cover Page)
Summit Therapeutics Inc. (SMMT) had Shares Outstanding (Cover Page) of 797.75 million shares as of 2026-07-17, per its 10-Q filed 2026-07-23.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-23
- 2026-07-17: Entity Common Stock, Shares Outstanding 797.75M shares.
- 2026-04-24: Entity Common Stock, Shares Outstanding 776.16M shares.
- 2026-02-17: Entity Common Stock, Shares Outstanding 775.37M shares.
- 2025-10-14: Entity Common Stock, Shares Outstanding 744.44M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-17 | 797.75M shares 10-Q · filed 2026-07-23 |
| 2026-04-24 | 776.16M shares 10-Q · filed 2026-04-30 |
| 2026-02-17 | 775.37M shares 10-K · filed 2026-02-23 |
| 2025-10-14 | 744.44M shares 10-Q · filed 2025-10-20 |
| 2025-08-05 | 742.85M shares 10-Q · filed 2025-08-11 |
| 2025-04-25 | 742.67M shares 10-Q · filed 2025-05-01 |
| 2025-02-18 | 737.68M shares 10-K · filed 2025-02-24 |
| 2024-10-23 | 737.45M shares 10-Q · filed 2024-10-30 |
| 2024-07-30 | 724.54M shares 10-Q · filed 2024-08-06 |
| 2024-04-22 | 701.98M shares 10-Q · filed 2024-05-01 |
| 2024-02-09 | 701.70M shares 10-K · filed 2024-02-20 |
| 2023-10-31 | 700.84M shares 10-Q · filed 2023-11-07 |
| 2023-08-02 | 697.69M shares 10-Q · filed 2023-08-09 |
| 2023-05-04 | 697.69M shares 10-Q · filed 2023-05-11 |
| 2023-03-07 | 697.69M shares 10-K · filed 2023-03-09 |
| 2022-11-02 | 201.32M shares 10-Q · filed 2022-11-09 |
| 2022-08-04 | 98.12M shares 10-Q · filed 2022-08-11 |
| 2022-05-04 | 98.12M shares 10-Q · filed 2022-05-11 |
| 2022-03-10 | 98.12M shares 10-K/A · filed 2022-12-21 |
| 2021-11-08 | 97.71M shares 10-Q · filed 2021-11-15 |
| 2021-08-05 | 97.38M shares 10-Q · filed 2021-08-12 |
| 2021-05-12 | 97.24M shares 10-Q · filed 2021-05-17 |
| 2021-03-24 | 82.92M shares 10-K · filed 2021-03-31 |
| 2020-11-11 | 82.26M shares 10-Q · filed 2020-11-16 |
| 2019-12-31 | 335.89M shares 20-F · filed 2020-04-30 |
| 2019-01-31 | 160.39M shares 20-F · filed 2019-03-29 |
| 2018-06-05 | 0.00 shares 6-K · filed 2018-06-05 |
| 2018-01-31 | 73.56M shares 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |